Home
Search

News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Browse All
Proposed Prescription Drug User Fee Act VII…
Biotechnology Innovation Organization (BIO) Chief Scientific Officer, E. Cartier Esham issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VII performance goals letter: “The Prescription Drug User Fee…
Learn more
Biden Drug Plan Adds Barriers to Seniors…
President Joe Biden today announced a slew of drug pricing reforms, including changes that would radically alter the widely successful Medicare program for seniors and people with disabilities. Rich Masters, BIO’s Chief Public Affairs and Advocacy…
Learn more
BIO Announces 2021 Start-up Stadium Winner:…
Annual competition takes place during BIO’s International Convention
Learn more
Letters, Testimony, & Comments
Browse All
BIO Supporting Oxitec’s Experimental Use Permit …
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and…
Learn more
BIO Signs Letter to House Leadership on Need to…
The undersigned organizations write to encourage policymakers to remove provisions in the Build Back Better Act that would curtail the effectiveness of Qualified Small Business Stock (QSBS) in incentivizing investment in innovative small businesses…
Learn more
BIO Testimony to House Agriculture Hearing on…
To meet the challenge of climate change, it is crucial to lead with science and U.S. innovation. We must incentivize the adoption of innovative, sustainable technologies and practices; and streamline and expedite regulatory pathways for breakthrough…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Learn more
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
Blog Posts
Browse all Blogs
Sickle Cell
For Sickle Cell Disease patients, every month is Sickle Cell Awareness Month
September 29, 2021
September is Sickle Cell Awareness Month—a time to reflect on how many people are affected by Sickle Cell Disease (SCD) and how much more needs to be done to fund research and put an end to it once and for all. However…
How Drug Price Controls End Up Hurting Patients
How Drug Price Controls End Up Hurting Patients
September 28, 2021
They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress…
Car Free Day
Car-Free Day: Could Biotech Make It a Thing of the Past?
September 21, 2021
The U.S. transportation sector leads all other sectors in greenhouse gas emissions. September 22 is International Car Free day, a day when folks make a pledge to walk or use public transportation with the goal of…